Emmaus Life Sciences, Inc. Stock Other OTC
Equities
EMMA
US29137T1016
Biotechnology & Medical Research
Financials (USD)
Sales 2021 | 20.61M | Sales 2022 | 18.39M | Capitalization | 12.9M |
---|---|---|---|---|---|
Net income 2021 | -15M | Net income 2022 | -10M | EV / Sales 2021 | 4.97 x |
Net Debt 2021 | 20.13M | Net Debt 2022 | 28.8M | EV / Sales 2022 | 2.27 x |
P/E ratio 2021 |
-5.16
x | P/E ratio 2022 |
-1.21
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 48.23% |
Managers | Title | Age | Since |
---|---|---|---|
George Sekulich
PSD | President | 59 | 19-04-30 |
Willis Lee
CHM | Chairman | 64 | 19-07-16 |
Yasushi Nagasaki
DFI | Director of Finance/CFO | 57 | 11-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Peu Zen
BRD | Director/Board Member | 72 | 19-07-16 |
Willis Lee
CHM | Chairman | 64 | 19-07-16 |
Ian Zwicker
BRD | Director/Board Member | 77 | 19-07-16 |
1st Jan change | Capi. | |
---|---|---|
-2.30% | 41.36B | |
+44.25% | 41.3B | |
+3.08% | 39.61B | |
-12.11% | 25.62B | |
+3.18% | 24.09B | |
-24.45% | 18.38B | |
+22.26% | 11.85B | |
-3.92% | 11.82B | |
+7.67% | 11.07B |